Fidelity Investments
LFCR icon

Fidelity Investments’s Lifecore Biomedical LFCR Stock Holding History

Fidelity Investments’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53K Buy
10,101
+7,880
+355% +$39.7K ﹤0.01% 4281
2026
Q1 		$8.26K Sell
2,221
-1,012
-31% -$6.99K ﹤0.01% 4811
2025
Q4 		$26.4K Buy
3,233
+422
+15% +$3.12K ﹤0.01% 4357
2025
Q3 		$20.7K Sell
2,811
-328
-10% -$2.48K ﹤0.01% 4345
2025
Q2 		$25.5K Buy
3,139
+722
+30% +$4.87K ﹤0.01% 4196
2025
Q1 		$17K Buy
2,417
+388
+19% +$2.41K ﹤0.01% 4293
2024
Q4 		$15.1K Buy
2,029
+504
+33% +$3.22K ﹤0.01% 4302
2024
Q3 		$7.52K Buy
1,525
+105
+7% +$549 ﹤0.01% 4519
2024
Q2 		$7.29K Sell
1,420
-70
-5% -$415 ﹤0.01% 4435
2024
Q1 		$7.91K Sell
1,490
-3,615
-71% -$25.9K ﹤0.01% 4354
2023
Q4 		$31.6K Buy
5,105
+3,209
+169% +$22.3K ﹤0.01% 3729
2023
Q3 		$14.3K Sell
1,896
-297
-14% -$2.71K ﹤0.01% 3971
2023
Q2 		$21.2K Buy
2,193
+166
+8% +$1.01K ﹤0.01% 3829
2023
Q1 		$7.65K Buy
2,027
+1,921
+1,812% +$10.7K ﹤0.01% 4234
2022
Q4 		$687 Sell
106
-333
-76% -$2.74K ﹤0.01% 4708
2022
Q3 		$4K Sell
439
-856
-66% -$8.7K ﹤0.01% 4400
2022
Q2 		$13K Buy
1,295
+36
+3% +$356 ﹤0.01% 4022
2022
Q1 		$15K Buy
+1,259
New +$14K ﹤0.01% 4109
2013
Q4 		– Sell
-632,536
Closed -$7.72M – 2659
2013
Q3 		$7.72M Sell
632,536
-1,128,854
-64% -$15.8M ﹤0.01% 2034
2013
Q2 		$23.3M Buy
+1,761,390
New +$24.4M ﹤0.01% 1595

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Fidelity Investments's LFCR Position: Q2 2026 in Review

Fidelity Investments increased its Lifecore Biomedical (LFCR) stake by 355% in Q2 2026, buying an estimated $39.7K and bringing the position to 10,101 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #4281.

Fidelity Investments first reported a position in LFCR in Q2 2013 and has held it in 20 quarters since. The position peaked at $23.3M in Q2 2013. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Fidelity Investments held 10,101 shares of Lifecore Biomedical worth $53K as of Q2 2026.
  • Fidelity Investments bought 7,880 Lifecore Biomedical shares in Q2 2026, an estimated $39.7K.
  • Lifecore Biomedical made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4281 holding.
  • Fidelity Investments first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 20 quarters since.
  • Fidelity Investments's Lifecore Biomedical position peaked at $23.3M in Q2 2013.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.